External consultation on the draft revised post-market review framework (deadline extension)

29 November 2022 - The Department of Health and Aged Care has received a request to extend the consultation period on ...

Read more →

Consultation on the revised PBS post-market review framework

20 October 2022 - The Department of Health and Aged Care is inviting stakeholders to provide feedback on a revised ...

Read more →

CADTH launches post-market drug evaluation program

1 September 2022 - CADTH is pleased to announce the launch of its new post-market drug evaluation program. ...

Read more →

Network collaborators announced for CADTH’s post-market drug evaluation network

8 August 2022 - CADTH is pleased to announce the successful collaborators of its inaugural Post-Market Drug Evaluation Network.  ...

Read more →

Core network partners announced for CADTH’s post-market drug evaluation network

10 June 2022 - CADTH is pleased to announce the four successful core network partners of its inaugural post-market drug ...

Read more →

CADTH establishes new post-market drug evaluation program

4 February 2022 - CADTH is pleased to announce it is expanding its expertise in the management of pharmaceuticals in ...

Read more →

Stakeholder consultation forum: post-market review of opiate dependence treatment program medicines

3 February 2022 - A stakeholder consultation forum for the post-market review of opiate dependence treatment program medicines will be ...

Read more →

Progress update: post-market review of medicines for smoking cessation

12 November 2021 - In June 2021, the Drug Utilisation Sub-Committee and the Economics Sub-Committee of the PBAC considered the report ...

Read more →

Final terms of reference and public consultation to the post-market review of opiate dependence treatment program medicines

17 August 2021 - The public consultation process for the post-market review of opiate dependence treatment program medicines is now ...

Read more →

Medical devices reforms: enhancements to post-market monitoring

5 July 2021 - This project has been established to enhance the adverse event reporting processes. ...

Read more →

FDA 'may require' post-marketing studies to analyse long-term effects of breast cancer drugs

21 June 2021 - The US FDA "may require” or seek agreement from sponsors to conduct post-marketing studies to analyse ...

Read more →

Post-market review of medicines for smoking cessation – public consultation on the draft report

7 June 2021 - The draft report for the post-market review of medicines for smoking cessation is available for public comment ...

Read more →

Post-market review of opiate dependence treatment program medicines

28 May 2021 - On 24 March 2021 it was announced the Department of Health will conduct a post-market review ...

Read more →

Post-market review of medicines available on the PBS Opiate Dependence Treatment Program

24 March 2021 - The Department of Health will conduct a post-market review of the medicines available under the Pharmaceutical ...

Read more →

Post-market review of medicines for smoking cessation – stakeholder forum outcome

15 February 2021 - A stakeholder forum was held for the post-market review of medicines for smoking cessation via webinar on ...

Read more →